Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Hanks, 1991, Outcome for lymph node dissection negative T-1b, T-2 (A-2, B prostate cancer treated with external beam radiation therapy in RTOG 77-06, Int J Radiat Oncol Biol Phys, 21, 1099, 10.1016/0360-3016(91)90757-U

Hanks, 1985, Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate, Int J Radiat Oncol Biol Phys, 11, 153, 10.1016/0360-3016(85)90374-8

Pilepich, 1986, Extended field (periaortic) irradiation in carcinoma of the prostate—analysis of RTOG 75-06, Int J Radiat Oncol Biol Phys, 12, 345, 10.1016/0360-3016(86)90349-4

Pilepich, 1987, Prognostic factors in carcinoma of the prostate—analysis of RTOG study 75-06, Int J Radiat Oncol Biol Phys, 13, 339, 10.1016/0360-3016(87)90007-1

Pilepich, 1990, Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy, Am J Clin Oncol, 13, 461, 10.1097/00000421-199012000-00001

Akakura, 1993, Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen, Cancer, 71, 2782, 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z

Pilepich, 1989, Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07, Int J Radiat Oncol Biol Phys, 16, 813, 10.1016/0360-3016(89)90500-2

Zagars, 1993, Prostate-specific antigen: an important marker for prostate cancer treated by external beam radiation therapy, Cancer, 72, 538, 10.1002/1097-0142(19930715)72:2<538::AID-CNCR2820720234>3.0.CO;2-S

Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702

Ritter, 1992, Prostate-specific antigen as a predictor of radiotherapy response and pattern of failure in localized prostate cancer, J Clin Oncol, 10, 1208, 10.1200/JCO.1992.10.8.1208

Kaplan, 1993, Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup, J Urol, 149, 519, 10.1016/S0022-5347(17)36133-5

Frazier, 1993, Is prostate specific antigen of clinical importance in evaluation outcome after radical prostatectomy?, J Urol, 149, 516, 10.1016/S0022-5347(17)36132-3

American Joint Committee on Cancer, 1988

Karnofsky, 1949, The clinical evaluation of chemotherapeutic agents in cancer, 191

Zelen, 1974, The randomization and stratification of patients to clinical trials, J Chron Dis, 27, 365, 10.1016/0021-9681(74)90015-0

Winchester, 1992, Standards for breastconservation treatment, CA Cancer J Clin, 242, 134, 10.3322/canjclin.42.3.134

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.2307/2281868

Kalbfleish, 1980, 167

Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951

Cox, 1977, The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate, Cancer, 40, 156, 10.1002/1097-0142(197707)40:1<156::AID-CNCR2820400126>3.0.CO;2-#

Scardino, 1986, The prognostic significance of postirradiation biopsy results in patients with prostatic carcinoma, J Urol, 135, 510, 10.1016/S0022-5347(17)45712-0

Kabalin, 1989, Identification of residual cancer in prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen, J Urol, 142, 326, 10.1016/S0022-5347(17)38746-3

Dugan, 1991, Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels, J Urol, 146, 1313, 10.1016/S0022-5347(17)38077-1

Stamey, 1987, Prostate specific antigen as a serum marker for adenocarcinoma of the prostate, N Engl J Med, 317, 909, 10.1056/NEJM198710083171501

Holtzman, 1991, The frequency and morbidity of local recurrence after definitive radiotherapy for stage T3 prostate cancer, J Urol, 146, 1578, 10.1016/S0022-5347(17)38171-5

Fuks, 1991, The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation, Int J Radiat Oncol Biol Phys, 21, 537, 10.1016/0360-3016(91)90668-T

Huggins, 1941, Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate, Cancer Res, 1, 293

Crawford, 1989, A controlled trial of leuprolide with and without flutamide in prostatic carcinoma, N Engl J Med, 321, 419, 10.1056/NEJM198908173210702

1993, 243

1993, 629

Kuban, 1987, The effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma, Urology, 30, 420, 10.1016/0090-4295(87)90372-4